Aytu Biopharma (AYTU) Tax Provisions (2014 - 2026)
Aytu Biopharma's (AYTU) quarterly Tax Provisions came in at $10000.0 in Q1 2026, up 110.0% year-on-year from $4761.9 in Q1 2025, and down 61.54% on a QoQ basis from $26000.0 in Q2 2025.
Aytu Biopharma (AYTU) Tax Provisions (2014 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 7 years of Tax Provisions data on file, last reported at $10000.0 in Q1 2026.
- On a quarterly basis, Tax Provisions rose 110.0% year-over-year to $10000.0 in Q1 2026; TTM through Mar 2026 was $36000.0, a 94.08% decrease from a year earlier, with the FY2025 full-year figure at $26000.0, down 98.62% from the prior year.
- Tax Provisions for Q1 2026 stood at $10000.0, down from $26000.0 in the prior quarter.
- Over the last five years, Tax Provisions for AYTU reached as high as $800000.0 in Q4 2023 and fell as low as -$23.0 million in Q2 2022.
- Historically, Tax Provisions has averaged -$2.3 million across 5 years, with a median of $26000.0 in 2025.
- Across the five-year window, Tax Provisions tumbled 135.37% in 2024 and soared 110.0% in 2026, its largest moves.
- Year by year, Tax Provisions stood at -$23.0 million in 2022, then jumped by 103.47% to $800000.0 in 2023, then tumbled by 135.38% to -$283000.0 in 2024, then jumped by 109.19% to $26000.0 in 2025, then slumped by 61.54% to $10000.0 in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $10000.0 in Q1 2026, $26000.0 in Q2 2025, and -$100000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 43.40 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Aytu Biopharma | 22.71 Mn | -4.01 Mn | 7.60 Mn | 10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | -283,000.00 |
| Sep 30, 2024 | 405,000.00 |
| Jun 30, 2024 | 586,000.00 |
| Mar 31, 2024 | 521,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Jun 30, 2022 | -23.05 Mn |
| Dec 31, 2021 | -3,000.00 |
| Sep 30, 2021 | -107,000.00 |
| Sep 30, 2014 | -23,910.00 |